Dong-A ST Co Overview

  • Year Founded
  • 1932

Year Founded

  • Status
  • Public

  • Employees
  • 1,691

Employees

  • Stock Symbol
  • 170900

Stock Symbol

  • Investments
  • 14

  • Share Price
  • $25.02
  • (As of Friday Closing)

Dong-A ST Co General Information

Description

Dong-A ST Co Ltd is a Korea-based company principally engaged in the manufacturing and distribution of specialty pharmaceuticals. The company also involves in the provision of medical devices, diagnostic detection, as well as overseas sale business. Its in-house developed original drugs are used for gastritis treatment, erectile dysfunction treatment, functional dyspepsia, oxazolidinone class antibiotic, and diabetes treatment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 64 Cheonho-daero
  • Dongdaemun-gu
  • Seoul, 02587
  • South Korea
+82
Primary Industry
Drug Discovery
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 64 Cheonho-daero
  • Dongdaemun-gu
  • Seoul, 02587
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dong-A ST Co Stock Performance

As of 20-Nov-2026, Dong-A ST Co’s stock price is $25.02. Its current market cap is $241M with 9.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$25.02 $25.52 $20.42 - $38.92 $241M 9.6M 8.49K $0.53

Dong-A ST Co Financials Summary

As of 30-Jun-2026, Dong-A ST Co has a trailing 12-month revenue of $593M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 400,893 518,596 485,900 535,797
Revenue 593,236 568,308 511,470 507,844
EBITDA 29,696 5,400 14,194 27,447
Net Income 5,988 (20,091) (896) 8,507
Total Assets 877,911 980,581 944,849 996,183
Total Debt 316,078 372,953 336,505 315,598
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Dong-A ST Co Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dong-A ST Co‘s full profile, request access.

Request a free trial

Dong-A ST Co Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Dong-A ST Co Ltd is a Korea-based company principally engaged in the manufacturing and distribution of specialty pharmac
Drug Discovery
Seoul, South Korea
1,691 As of 2025

Daegu, South Korea
 

Tokyo, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dong-A ST Co Competitors (39)

One of Dong-A ST Co’s 39 competitors is Astrogen, a Venture Capital-Backed company based in Daegu, South Korea.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Astrogen Venture Capital-Backed Daegu, South Korea
Astellas Pharma Corporation Tokyo, Japan
SK Biopharmaceuticals Corporation Seongnam, South Korea
Savara Formerly VC-backed Yardley, PA
CTI BioPharma Formerly VC-backed Seattle, WA
You’re viewing 5 of 39 competitors. Get the full list »

Dong-A ST Co Patents

Dong-A ST Co Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026024144-A1 Novel compound as polymerase theta inhibitor, and pharmaceutical composition comprising thereof Pending 26-Jul-2024
WO-2025254414-A1 Ahr modulator compound with improved solubility Pending 03-Jun-2024
WO-2025254418-A1 Crystalline polymorph of aminopyrimidine derivative and preparation method therefor Pending 03-Jun-2024
AU-2024374922-A1 Pharmaceutical composition for prevention or treatment of nonalcoholic fatty liver disease Pending 06-Nov-2023
EP-4806437-A1 Pharmaceutical composition for prevention or treatment of nonalcoholic fatty liver disease Pending 06-Nov-2023 A61K31/506
To view Dong-A ST Co’s complete patent history, request access »

Dong-A ST Co Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dong-A ST Co Investments & Acquisitions (14)

Dong-A ST Co’s most recent deal was a Later Stage VC with People & Technology for . The deal was made on 07-Apr-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
People & Technology 07-Apr-2026 Later Stage VC Electronic Equipment and Instruments
Ecowin 28-May-2025 Merger/Acquisition Agricultural Chemicals
Idience 20-May-2024 Later Stage VC Drug Discovery
BreezeBio 23-Jan-2024 Later Stage VC Drug Delivery
AbTis 20-Dec-2023 Merger/Acquisition Biotechnology
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Dong-A ST Co ESG

Risk Overview

Risk Rating

Updated June, 30, 2025

31.18 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,271

Rank

Percentile

Pharmaceuticals

Industry

of 908

Rank

Percentile

Pharmaceuticals

Subindustry

of 406

Rank

Percentile

To view Dong-A ST Co’s complete esg history, request access »

Dong-A ST Co Exits (2)

Dong-A ST Co’s most recent exit was on 08-Nov-2022 from MetaVia (Biotechnology). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
MetaVia (Biotechnology) 08-Nov-2022 Completed
ScienceMedic 01-Mar-2015 Seed Round Completed
To view Dong-A ST Co’s complete exits history, request access »

Dong-A ST Co Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
AbTis Suwon, South Korea 2016
Ecowin Daegu, South Korea 2008
Dong-A Chammed Gunpo-si, South Korea 2005

Dong-A ST Co FAQs

  • When was Dong-A ST Co founded?

    Dong-A ST Co was founded in 1932.

  • Where is Dong-A ST Co headquartered?

    Dong-A ST Co is headquartered in Seoul, South Korea.

  • What is the size of Dong-A ST Co?

    Dong-A ST Co has 1,691 total employees.

  • What industry is Dong-A ST Co in?

    Dong-A ST Co’s primary industry is Drug Discovery.

  • Is Dong-A ST Co a private or public company?

    Dong-A ST Co is a Public company.

  • What is Dong-A ST Co’s stock symbol?

    The ticker symbol for Dong-A ST Co is 170900.

  • What is the current stock price of Dong-A ST Co?

    As of 20-Nov-2026 the stock price of Dong-A ST Co is $25.02.

  • What is the current market cap of Dong-A ST Co?

    The current market capitalization of Dong-A ST Co is $241M.

  • What is Dong-A ST Co’s current revenue?

    The trailing twelve month revenue for Dong-A ST Co is $593M.

  • Who are Dong-A ST Co’s competitors?

    Astrogen, Astellas Pharma, SK Biopharmaceuticals, Savara, and CTI BioPharma are some of the 39 competitors of Dong-A ST Co.

  • What is Dong-A ST Co’s annual earnings per share (EPS)?

    Dong-A ST Co’s EPS for 12 months was $0.53.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process